Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Assessment of extrapyramidal disorders.

Literature DB >> 6452152

Assessment of extrapyramidal disorders.

C D Marsden, M Schachter.

Abstract

Entities: Disease

Mesh：

Year: 1981 PMID： 6452152 PMCID： PMC1401576 DOI： 10.1111/j.1365-2125.1981.tb01118.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

118 in total

1. Physical factors concerned with the stiffness of normal and diseased joints.

Authors: V WRIGHT; R J JOHNS
Journal: Bull Johns Hopkins Hosp Date: 1960-04

2. An objective method of evaluating muscle tightness; preliminary observations on the effectiveness of various procedures in producing muscle relaxation in the hemiplegic extremity.

Authors: W J LA JOIE; J W GERSTEN
Journal: Arch Phys Med Rehabil Date: 1952-10 Impact factor: 3.966

3. Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use.

Authors: D A KARNOFSKY; J H BURCHENAL; G C ARMISTEAD; C M SOUTHAM; J L BERNSTEIN; L F CRAVER; C P RHOADS
Journal: AMA Arch Intern Med Date: 1951-04

Review 4. [Modern treatment of parkinsonism].

Authors: W Birkmayer; E Neumayer
Journal: Z Neurol Date: 1972

5. Validity of cross-over trials.

Authors: D W Vere
Journal: Br J Clin Pharmacol Date: 1979-07 Impact factor: 4.335

6. Amantadine hydrochloride treatment of tardive dyskinesia.

Authors: B L Decker; J M Davis; D S Jonowsky; M K el-Yousef; H J Sekerke
Journal: N Engl J Med Date: 1971-10-07 Impact factor: 91.245

7. Pharmacotherapeutic trials in tardive dyskinesia.

Authors: A V Mackay; G P Sheppard
Journal: Br J Psychiatry Date: 1979-12 Impact factor: 9.319

8. Parkinsonism: onset, progression and mortality.

Authors: M M Hoehn; M D Yahr
Journal: Neurology Date: 1967-05 Impact factor: 9.910

9. Effect of cholinergic and anticholinergic agents on tardive dyskinesia.

Authors: H L Klawans; R Rubovits
Journal: J Neurol Neurosurg Psychiatry Date: 1974-08 Impact factor: 10.154

10. The prevalence of presumed tardive dyskinesia in psychiatric inpatients and outpatients.

Authors: J Kane; J Wegner; S Stenzler; P Ramsey
Journal: Psychopharmacology (Berl) Date: 1980 Impact factor: 4.530

32 in total

1. Determinants of gait in the elderly parkinsonian on maintenance levodopa/carbidopa therapy.

Authors: S G Bowes; P K Clark; A L Leeman; C J O'Neill; C Weller; P W Nicholson; A A Deshmukh; S M Dobbs; R J Dobbs
Journal: Br J Clin Pharmacol Date: 1990-07 Impact factor: 4.335

2. Scales for rating motor impairment in Parkinson's disease: studies of reliability and convergent validity.

Authors: L Henderson; C Kennard; T J Crawford; S Day; B S Everitt; S Goodrich; F Jones; D M Park
Journal: J Neurol Neurosurg Psychiatry Date: 1991-01 Impact factor: 10.154

3. Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography.

Authors: H Karbe; M Grond; M Huber; K Herholz; J Kessler; W D Heiss
Journal: J Neurol Date: 1992-02 Impact factor: 4.849

4. Buspirone in progressive myoclonus epilepsy.

Authors: M R Pranzatelli; D Franz; E Tate; J M Martens
Journal: J Neurol Neurosurg Psychiatry Date: 1993-01 Impact factor: 10.154

Review 5. Parkinson's disease.

Authors: E C Wolters; D B Calne
Journal: CMAJ Date: 1989-03-01 Impact factor: 8.262

6. Gait measures with a triaxial accelerometer among patients with neurological impairment.

Authors: Patrik Fazio; Gino Granieri; Ilaria Casetta; Edward Cesnik; Sante Mazzacane; Pietro Caliandro; Francesco Pedrielli; Enrico Granieri
Journal: Neurol Sci Date: 2012-03-25 Impact factor: 3.307

Review 7. Assessment of anti-psychotic drugs.

Authors: A V Mackay
Journal: Br J Clin Pharmacol Date: 1981-03 Impact factor: 4.335